This quarterly report tomorrow shouldn't be looked at as a binary event. If we get very positive news, wonderful. If we don't hear much new, I will take that as positive as Leo could be locked into a quiet period or is of the belief no use to spill the beans until human trial success is confirmed.
Of course, it news is negative, that would be another matter and though it would be disappointing, it would not be fatal for IPIX or Brilacidin in other indications.
The world needs to be pulling for the positive, for without Brilacidin I don't know what other drug is up and coming that is showing as much promise as B at the current time.
News 
Market Data 
Discover 
